JPS5912990B2 - 人間の癌胚抗原の精製方法 - Google Patents
人間の癌胚抗原の精製方法Info
- Publication number
- JPS5912990B2 JPS5912990B2 JP48051263A JP5126373A JPS5912990B2 JP S5912990 B2 JPS5912990 B2 JP S5912990B2 JP 48051263 A JP48051263 A JP 48051263A JP 5126373 A JP5126373 A JP 5126373A JP S5912990 B2 JPS5912990 B2 JP S5912990B2
- Authority
- JP
- Japan
- Prior art keywords
- column
- carcinoembryonic antigen
- particle size
- gel
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 11
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 title claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 33
- 239000000499 gel Substances 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 17
- 229920002307 Dextran Polymers 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 229920000936 Agarose Polymers 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 238000009826 distribution Methods 0.000 claims description 6
- 238000005342 ion exchange Methods 0.000 claims description 6
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 5
- 239000005695 Ammonium acetate Substances 0.000 claims description 5
- 229940043376 ammonium acetate Drugs 0.000 claims description 5
- 235000019257 ammonium acetate Nutrition 0.000 claims description 5
- 239000011543 agarose gel Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000012458 free base Substances 0.000 claims description 3
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 17
- 229920005654 Sephadex Polymers 0.000 description 7
- 239000012507 Sephadex™ Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 150000002500 ions Chemical group 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 229910052743 krypton Inorganic materials 0.000 description 2
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/02—Column or bed processes
- B01J47/04—Mixed-bed processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/26—Cation exchangers for chromatographic processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US252700 | 1972-05-12 | ||
| US252700A US3867363A (en) | 1970-06-01 | 1972-05-12 | Carcinoembryonic antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS4947521A JPS4947521A (en, 2012) | 1974-05-08 |
| JPS5912990B2 true JPS5912990B2 (ja) | 1984-03-27 |
Family
ID=22957148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP48051263A Expired JPS5912990B2 (ja) | 1972-05-12 | 1973-05-10 | 人間の癌胚抗原の精製方法 |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5912990B2 (en, 2012) |
| AU (1) | AU468779B2 (en, 2012) |
| BE (1) | BE799405A (en, 2012) |
| CA (1) | CA948991A (en, 2012) |
| CH (1) | CH583036A5 (en, 2012) |
| DD (1) | DD107293A5 (en, 2012) |
| DE (1) | DE2323955A1 (en, 2012) |
| DK (1) | DK133559B (en, 2012) |
| FR (1) | FR2184753B1 (en, 2012) |
| GB (1) | GB1378134A (en, 2012) |
| IL (1) | IL42119A (en, 2012) |
| IT (1) | IT998101B (en, 2012) |
| NL (1) | NL7306346A (en, 2012) |
| SE (1) | SE403912B (en, 2012) |
| ZA (1) | ZA732770B (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146603A (en) * | 1977-02-18 | 1979-03-27 | Research Corporation | Tumor specific glycoproteins and method for detecting tumorigenic cancers |
| GB2122641B (en) * | 1982-06-07 | 1986-08-06 | Otto A Gansow | Metal chelate conjugated monoclonal antibodies where in the metal is an emitter |
| JPS6076395A (ja) * | 1983-10-03 | 1985-04-30 | Dainippon Screen Mfg Co Ltd | 印刷版の溶出装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3697638A (en) * | 1970-06-01 | 1972-10-10 | Hoffmann La Roche | Antigens |
-
1973
- 1973-04-11 CH CH519673A patent/CH583036A5/xx not_active IP Right Cessation
- 1973-04-20 IT IT23343/73A patent/IT998101B/it active
- 1973-04-24 ZA ZA732770A patent/ZA732770B/xx unknown
- 1973-04-25 CA CA169,501A patent/CA948991A/en not_active Expired
- 1973-04-27 IL IL42119A patent/IL42119A/en unknown
- 1973-04-30 AU AU54989/73A patent/AU468779B2/en not_active Expired
- 1973-05-07 DK DK249773AA patent/DK133559B/da not_active IP Right Cessation
- 1973-05-07 NL NL7306346A patent/NL7306346A/xx unknown
- 1973-05-10 JP JP48051263A patent/JPS5912990B2/ja not_active Expired
- 1973-05-10 DD DD170753A patent/DD107293A5/xx unknown
- 1973-05-11 GB GB2261173A patent/GB1378134A/en not_active Expired
- 1973-05-11 FR FR7317188A patent/FR2184753B1/fr not_active Expired
- 1973-05-11 BE BE131003A patent/BE799405A/xx not_active IP Right Cessation
- 1973-05-11 SE SE7306698-7A patent/SE403912B/xx unknown
- 1973-05-11 DE DE2323955A patent/DE2323955A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL7306346A (en, 2012) | 1973-11-14 |
| IT998101B (it) | 1976-01-20 |
| BE799405A (fr) | 1973-11-12 |
| GB1378134A (en) | 1974-12-18 |
| AU5498973A (en) | 1974-10-31 |
| AU468779B2 (en) | 1976-01-22 |
| CA948991A (en) | 1974-06-11 |
| ZA732770B (en) | 1974-04-24 |
| SE403912B (sv) | 1978-09-11 |
| FR2184753A1 (en, 2012) | 1973-12-28 |
| FR2184753B1 (en, 2012) | 1977-11-04 |
| IL42119A (en) | 1976-08-31 |
| CH583036A5 (en, 2012) | 1976-12-31 |
| DD107293A5 (en, 2012) | 1974-07-20 |
| DE2323955A1 (de) | 1973-11-22 |
| DK133559C (en, 2012) | 1977-02-21 |
| IL42119A0 (en) | 1973-06-29 |
| DK133559B (da) | 1976-06-08 |
| JPS4947521A (en, 2012) | 1974-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Flodin et al. | Fractionation of human-serum proteins by gel filtration | |
| Baumstark et al. | A preparative method for the separation of 7S gamma globulin from human serum | |
| Agnew et al. | Purification of the tetrodotoxin-binding component associated with the voltage-sensitive sodium channel from Electrophorus electricus electroplax membranes. | |
| Porath et al. | Agar derivatives for chromatography, electrophoresis and gel-bound enzymes: III. Rigid agarose gels cross-linked with divinyl sulphone (DVS) | |
| US3697638A (en) | Antigens | |
| Porath | Cross-linked dextrans as molecular sieves | |
| US3867363A (en) | Carcinoembryonic antigens | |
| US4138287A (en) | Purifying and isolating method for hepatitis virus to use in preparing vaccine | |
| US4756834A (en) | Phase supports for the partition chromatography of macromolecules, a process for their preparation and their use | |
| CA1110617A (en) | Glycoprotein and process for isolating it | |
| US4180499A (en) | Carcinoembryonic antigens | |
| US3956258A (en) | Carcinoembryonic antigens | |
| CA1073565A (en) | Separation of macromolecules | |
| GB1586240A (en) | Tissue specific protein and process for preparing same | |
| Worwood et al. | Absorption of 59Fe in the rat: iron binding substances in the soluble fraction of intestinal mucosa | |
| US4086217A (en) | Carcinoembryonic antigens | |
| JPS5912990B2 (ja) | 人間の癌胚抗原の精製方法 | |
| US4223002A (en) | Isolation of alpha1 -fetoprotein | |
| US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| JPS636553B2 (en, 2012) | ||
| Ehwald et al. | Chromatography based on membrane separation with vesicular packing material | |
| Bassett | Large scale preparation of wheat germ agglutinin | |
| Jackson et al. | Physicochemical properties of some glycopeptides released from human erythrocyte membranes by trypsin | |
| Polson et al. | A quantitative theory for gel-exculsion chromatography | |
| US6723539B1 (en) | Absorbent medium containing particles of chopped cellulose or agarose sponge material having functional groups |